The OMERS ADMINISTRATION Corp Has $1,664,000 Stake in DENTSPLY SIRONA Inc (XRAY)

The OMERS ADMINISTRATION Corp Has $1,664,000 Stake in DENTSPLY SIRONA Inc (XRAY)

OMERS ADMINISTRATION Corp held its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,000 shares of the company’s stock at the end of the third quarter. OMERS ADMINISTRATION Corp’s holdings in DENTSPLY SIRONA were worth $1,664,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Citizens Financial Group Inc RI raised its position in DENTSPLY SIRONA by 0.3% in the second quarter. Citizens Financial Group Inc RI now owns 8,739 shares of the company’s stock valued at $542,000 after buying an additional 25 shares in the last quarter. Telemus Capital LLC increased its stake in DENTSPLY SIRONA by 0.4% in the third quarter. Telemus Capital LLC now owns 7,852 shares of the company’s stock valued at $467,000 after buying an additional 35 shares in the last quarter. TCW Group Inc. increased its stake in DENTSPLY SIRONA by 0.4% in the second quarter. TCW Group Inc. now owns 18,850 shares of the company’s stock valued at $1,169,000 after buying an additional 75 shares in the last quarter. Security National Bank of SO Dak increased its stake in DENTSPLY SIRONA by 0.4% in the second quarter. Security National Bank of SO Dak now owns 17,491 shares of the company’s stock valued at $1,085,000 after buying an additional 75 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its stake in DENTSPLY SIRONA by 0.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 19,460 shares of the company’s stock valued at $1,157,000 after buying an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 93.41% of the company’s stock.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) traded down 1.56% during trading on Thursday, reaching $55.67. The company had a trading volume of 2,175,943 shares. The company has a market capitalization of $12.85 billion, a price-to-earnings ratio of 29.09 and a beta of 1.23. DENTSPLY SIRONA Inc has a one year low of $53.43 and a one year high of $65.83. The company has a 50-day moving average price of $58.55 and a 200 day moving average price of $60.07.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, November 4th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.03. The company had revenue of $954.20 million for the quarter, compared to analysts’ expectations of $967.68 million. DENTSPLY SIRONA had a net margin of 11.15% and a return on equity of 8.04%. The business’s revenue was up 47.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.66 EPS. Analysts expect that DENTSPLY SIRONA Inc will post $2.77 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 13th. Stockholders of record on Friday, December 30th were given a dividend of $0.0775 per share. This represents a $0.31 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date was Wednesday, December 28th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.07. DENTSPLY SIRONA’s dividend payout ratio is 15.98%.

Several analysts have issued reports on the company. Zacks Investment Research downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Wednesday, November 2nd. JPMorgan Chase & Co. assumed coverage on DENTSPLY SIRONA in a research note on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 price target on the stock. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 price target on the stock in a research note on Monday, December 5th. Morgan Stanley raised DENTSPLY SIRONA from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $65.00 to $69.00 in a research note on Tuesday, November 1st. They noted that the move was a valuation call. Finally, Robert W. Baird reissued an “outperform” rating and issued a $67.00 price target (down previously from $69.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, October 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company’s stock. DENTSPLY SIRONA presently has an average rating of “Buy” and an average price target of $66.78.

In other news, CEO James G. Mosch sold 30,400 shares of the stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $60.93, for a total transaction of $1,852,272.00. Following the transaction, the chief executive officer now owns 75,283 shares of the company’s stock, valued at approximately $4,586,993.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.20% of the stock is owned by corporate insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Related posts

Leave a Comment